Protein C activation during the initial phase of experimental acute pancreatitis in the rabbit

Digestive Surgery

Volumn 16, Issue 6, 1999, Pages 486-495

  Ottesen, L H ^a,c   Bladbjerg, E M ^b   Osman, M ^a   Lausten, S B ^a   Jacobsen, N O ^a   Gram, J ^b   Jensen, S L ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Acute necrotising pancreatitis; Coagulation; Fibrinolysis; Haemostatic activation; Protein C; Rabbit

Indexed keywords

ACTIVATED PROTEIN C; ANTITHROMBIN; BLOOD CLOTTING FACTOR 7; CHENODEOXYCHOLIC ACID; FIBRINOGEN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEMORRHAGIC PANCREATITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FIBRINOLYSIS; MALE; NONHUMAN; PANCREAS DUCT; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; RABBIT;

EID: 0033375143     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000018774     Document Type: Article

References (51)

1. Tenner S, Sica G, Hughes M, Noordhoek E, Feng S, Zinner M, Banks PA: Relationship of necrosis to organ failure in severe acute pancreatitis. Gastroenterology 1997;113:899-903.
2. de Beaux AC, Palmer KR, Carter DC: Factors influencing morbidity and mortality in acute pancreatitis: An analysis of 279 cases. Gut 1995;37:121-126.
3. Karimgani I, Porter KA, Langevin RE, Banks PA: Prognostic factors in sterile pancreatic necrosis. Gastroenterology 1992;103:1636-1640.
4. Pitchumoni CS, Agarwal N, Jain NK: Systemic complications of acute pancreatitis. Am J Gastroenterol 1988;83:597-606.
5. Gross V, Leser HG, Heinisch A, Scholmerich J: Inflammatory mediators and cytokines: New aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterology 1993;40:522-530.
6. Lasson A, Ohlsson K: Consumptive coagulopathy, fibrinolysis and protcase-antiprotease interactions during acute human pancreatitis. Thromb Res 1986;41:167-183.
7. Shinowara GY, Stutman LJ, Walthers MI, Ruth ME, Walker EJ: Hypercoagulability in acute pancreatitis. Am J Surg 1963;105:714-719.
8. Greipp PR, Brown JA, Gralnick HR: Defibrination in acute pancreatitis. Ann Intern Med 1972;76:73-76.
9. Ranson JH, Lackner H, Berman IR, Schinella R: The relationship of coagulation factors to clinical complications of acute pancreatitis. Surgery 1977;81:502-511.
10. Kwaan HC, Anderson MC, Gramatica L: A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis. Surgery 1971;69:663-672.
11. Satake K, Uchima K, Umeyama K, Appert HE, Howard JM: The effects upon blood coagulation in dogs of experimentally induced pancreatitis and the infusion of pancreatic juice. Surg Gynecol Obstet 1981;153:341-345.
12. Agarwal MB, Kamdar MS, Bapat RD, Mehta BC, Rao S, Rao PN: Consumptive coagulopathy and fibrinolysis in experimental acute pancreatitis. J Postgrad Med 1982;28:214-217.
13. Izquierdo R, Sandberg L, Nora MO, Squillaci G, Hoppensteadt D, Walenga J, Fareed J, Prinz RA: Comparative study of protease inhibitors on coagulation abnormalities in canine pancreatitis. J Surg Res 1984;36:606-613.
14. Rydzcwska G, Kosidlo S, Gabryelewicz A, Rydzewski A: Tissue plasminogen activator, plasminogen activator inhibitor, and other parameters of fibrinolysis in the early stages of taurocholate acute pancreatitis in rats. Int J Pancreatol 1992;11:161-168.
15. Etoh Y, Sumi H, Tsushima H, Maruyama M, Mihara H: Fibrinolytic enzymes in ascites during experimental acute pancreatitis in rats. Int J Pancreatol 1992;12:127-137.
16. Mussoni L, Raczka E, Chmielewska J, Donati MB, Latallo ZS: Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate S-2251. Thromb Res 1979;15:341-349.
17. Haggroth L, Mattsson C, Friberg J: Inhibition of the human tissue plasminogen activator in plasma from different species. Thromb Res 1984;33:583-594.
18. Hassett MA, Krishnamurti C, Barr CF, Alving BM: The rabbit as a model for studies of fibrinolysis. Thromb Res 1986;43:313-323.
19. Albrechtsen OK, Brakman P, Astrup T: The defibrination syndrome in rabbits following infusion of tissue thromboplastin in the jugular vein. Thromb Diath Haemorrh 1970;24:113-128.
20. Tvedskov TF, Vad H, Bendix-Hansen K, Albrechtsen OK, Gram J: Studies of the initial anticoagulant response in tissue-thromboplastin induced intravascular coagulation. Blood Coagul Fibrinolysis 1996;7:595-601.
21. Tvedskov TF, Vad H, Albrechtsen OK, Gram J: Tissue thromboplastin induces rapid inhibition of fibrinolysis in rabbits. Fibrinolysis 1996;10:143-149.
22. Vad H, Tvedskov TF, Hansen KB, Albrechtsen OK, Jespersen J, Gram J: Anticoagulant properties of rabbit lungs in tissue thromboplastin-induced intravascular coagulation. Thromb Haemost 1997;77:679-684.
23. Hong SS, Chin DS, Cho TS, Kim SE: Experimental pancreatitis induced by alcohol and bile in rabbits: Studies on changes of serum enzymes and histopathologic findings. Ann Surg 1962;156:929-939.
24. Lankish PG, Ihse I: Bile-induced acute experimental pancreatitis. Scand J Gastroenterol 1987;22:257-260.
25. Senninger N: Bile-induced pancreatitis. Eur Surg Res 1992;24(suppl 1):68-73.
26. Banerjee AK, Galloway SW, Kingsnorth AN: Experimental models of acute pancreatitis. Br J Surg 1994;81:1096-1103.
27. Osman MO, Lausten SB, Jakobsen NO, Kristensen JU, Deleuran B, Larsen CG, Jensen SL: Graded experimental pancreatitis: Monitoring of a renewed rabbit model focusing on the production of interleukin-8 (IL-8) and CD11b CD18. Eur J Gastroenterol Hepatol 1999;11: 137-149.
28. Almdahl SM, Nilsen DW, Østerud B, Sorlie DG, Vaage J: Thromboplastin activities and monocytes in the coronary circulation of reperfused human myocardium. No effect of preoperative treatment with n-3 fatty acids. Scand J Thorac Cardiovasc Surg 1993;27:81-86.
29. Bladbjerg EM, Marckmann P, Sandstrom B, Jespersen J: Non-fasting factor VII coagulant activity (FVII:C) increased by high-fat diet. Thromb Haemost 1994;71:755-758.
30. Jespersen J, Sidelmann J: A study of the conditions and accuracy of the thrombin time assay of plasminogen. Acta Haematol 1982;67:2-7.
31. Gram J, Jespersen J: Increased concentration of heparin cofactor II in diabetic patients, and possible effects on thrombin inhibition assay of antithrombin III. Clin Chem 1989;35:52-55.
32. Carstairs KC: The identification of platelets and platelet antigens in histological sections. J Pathol Bacteriol 1965;61:443-448.
33. Matthews JN, Altman DG, Campbell MJ. Royston P: Analysis of serial measurements in medical research. BMJ 1990;300:230-235.
34. Marlar RA, Kleiss AJ, Griffin JH: Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982;59:1067-1072.
35. Clouse LH, Comp PC: The regulation of hemostasis: The protein C system. N Engl J Med 1986;314:1298-1304.
36. Marlar RA, Endres BJ, Miller C: Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood 1985;66:59-63.
37. Hesselvic JF, Malm J, Dahlback B, Blomback M: Protein C, protein S and C4b-binding protein in severe infection and septic shock. Thromb Haemost 1991;65:126-129.
38. Finjnvandraat K, Derkx B, Peters M, Bijlmer R, Sturk A. Prins MH, van Deventer SJ, ten Cate JW: Coagulation activation and tissue necrosis in meningococcal septic shock: Severely reduced protein C levels predict a high mortality. Thromb Haemost 1995;73:15-20.
39. Emekli NB, Ulutin ON: The protective effect of autoprothrombin II anticoagulant on experimental DIC in animals. Haematologica 1980; 65:644-651.
40. Taylor FB, Jr., Chang A, Esmon CT, D'Angelo A, Vigano-D'Angelo S, Blick KE: Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest 1987;79:918-925.
41. Madden RM, Ward M, Marlar RA: Protein C activity levels in endotoxin-induced disseminated intravascular coagulation in a dog model. Thromb Res 1989;55:297-307.
42. Wilson RF, Mammen E, Robson MC, Heggers JP, Souillier G, dePoli PA: Antithrombin, prekallikrein, and fibronectin levels in surgical patients. Arch Surg 1985;121:635-640.
43. Levi M, ten Cate H, van der Poll T, van Deventer SJH: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270:975-980.
44. Østerud B, Flægstad T: Increased tissue thromboplast in activity in monocytes of patients with meningococceal infection: Related to an unfavorable prognosis. Thromb Haemost 1983;49: 5-7.
45. Levi M, ten Cate H, Bauer KA, van der Poll T, Edginton TS, Buller HR, van Deventer SJH, Hack CE, ten Cate JW, Rosenberg RD: Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994;93:114-120.
46. Taylor FB Jr, Chang A, Ruf W, Morrissey JH, Hinshaw L, Catlett R, Blick K, Edgington TS: Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody. Circ Shock 1991;33:127-134.
47. Norman JG, Fink GW, Franz MG: Acute pancreatitis induces intrapancreatic tumor necrosis factor gene expression. Arch Surg 1995;130: 966-970.
48. Norman J, Franz M, Riker A, Fabri PJ, Gower WR: Rapid elevation of systemic cytokines during acute pancreatitis and their origination within the pancreas. Surg Forum 1994;45:148-150.
49. Liehr H, Grun M, Seelig R, Seelig HP: Endotoxinämic bei acuter Pancreatitis. Leber Magen Darm 1980;10:259-268.
50. Exley AR, Leese T, Holliday MP, Swann RA, Cohen J: Endotoxaemia and serum tumour necrosis factor as prognostic markers in severe acute pancreatitis. Gut 1992;33:1126-1128.
51. Key NS, Slungaard A, Dandclet L, Nelson SC, Moertel C, Styles LA, Kuypers FA, Bach RR: Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood 1998;91:4216-4223.